Anti-Aging pill? MitoQ trial targets blood vessel decline in seniors
NCT ID NCT04851288
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This study tests whether a daily supplement called MitoQ can improve blood vessel function in people aged 60 and older. Aging often leads to stiff arteries and poor blood vessel health, raising heart disease risk. The trial involves 112 participants taking either MitoQ or a placebo for 3 months to see if it reverses age-related vascular damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Colorado Boulder
Boulder, Colorado, 80309, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your heart hold the key to Alzheimer's prevention?
- The aging Body's hidden water shift: a new study investigates
- Rewiring the veteran brain: could visual training counteract cognitive decline?
- Can a simple walk test reveal hidden health risks in aging?
- A handful of walnuts a day: could it keep the aging mind sharp?
- Shining a light on brain aging: could NIR boost memory?